Cargando…
Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy
Hepatocellular carcinoma (HCC) ranks among the leading cancer-related causes of morbidity and mortality worldwide. Downstaging of HCC has prevailed as a key method to curative therapy for patients who present with unresectable HCC outside of the listing criteria for liver transplantation (LT). Even...
Autores principales: | Frankul, Leana, Frenette, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111105/ https://www.ncbi.nlm.nih.gov/pubmed/34007804 http://dx.doi.org/10.14218/JCTH.2020.00037 |
Ejemplares similares
-
Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021) -
Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021) -
Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
por: Filipec Kanižaj, Tajana, et al.
Publicado: (2022) -
Downstaging of Hepatocellular Carcinoma Prior to Liver Transplant: Is There a Role for Adjuvant Sorafenib in Locoregional Therapy?
por: Vagefi, Parsia A., et al.
Publicado: (2010) -
Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)